Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders

Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation prope...

Descripción completa

Detalles Bibliográficos
Autores: Folle, Camila, Sánchez-López, E. (Elena), Mallandrich Miret, Mireia, Díaz-Garrido, Natalia, Suñer Carbó, J. (Joaquim), Halbaut, Lyda, Carvajal Vidal, Paulina Andrea, Marqués Villavecchia, Ana M., Espina García, Marta, Badía Palacín, Josefa, Baldomà Llavinés, Laura, García López, María Luisa, Calpena Campmany, Ana Cristina
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/219683
Acceso en línea:https://hdl.handle.net/2445/219683
Access Level:acceso abierto
Palabra clave:Pell
Nanopartícules
Emulsions (Farmàcia)
Skin
Nanoparticles
Emulsions (Pharmacy)
id ES_45e02e231ec6dfdc51ba1a585fbb8927
oai_identifier_str oai:recercat.cat:2445/219683
network_acronym_str ES
network_name_str España
repository_id_str
spelling Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disordersFolle, CamilaSánchez-López, E. (Elena)Mallandrich Miret, MireiaDíaz-Garrido, NataliaSuñer Carbó, J. (Joaquim)Halbaut, LydaCarvajal Vidal, Paulina AndreaMarqués Villavecchia, Ana M.Espina García, MartaBadía Palacín, JosefaBaldomà Llavinés, LauraGarcía López, María LuisaCalpena Campmany, Ana CristinaPellNanopartículesEmulsions (Farmàcia)SkinNanoparticlesEmulsions (Pharmacy)Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation properties cause its fast elimination and, to avoid this problem, thymol has been loaded into nanostructured lipid carriers (TH-NLCs). Moreover, to increase the suitability of these systems for skin applications, several surface functionalization strategies of TH-NLCs had been assessed. Among the different molecules, phosphatidylcholine-TH-NLCs demonstrated to be safe as well as to provide high antioxidant activity in cellular studies. Therefore, to administer these systems to the skin, functionalized TH-NLCs were dispersed into a carbomer gel developing semi-solid formulations. Rheological properties, porosity and extensibility of TH dispersed in carbomer as well as phosphatidylcholine-TH-NLCs were assessed demonstrating suitable properties for dermal applications. Moreover, both formulations were applied in healthy volunteers demonstrating that gel-phosphatidylcholine-TH-NLCs were able to increase in skin hydration, decrease water loss and reduce skin sebum. Therefore, gel-phosphatidylcholine-TH-NLCs proved to be a suitable system for skin pathologies linked with high sebum generation, loss of hydration and high oxidation, such as acne vulgaris. Keywords: Acne; Dermal; Lipid nanoparticles; Nanostructured lipid carriers; Thymol.Elsevier B.V.2025202520242025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion1 p.application/pdfhttps://hdl.handle.net/2445/219683Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1016/j.ijpharm.2023.123732International Journal of Pharmaceutics, 2024, vol. 651https://doi.org/10.1016/j.ijpharm.2023.123732cc-by-nc-nd (c) Camila Folle, et al., 2024http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2196832026-05-29T05:05:01Z
dc.title.none.fl_str_mv Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
title Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
spellingShingle Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
Folle, Camila
Pell
Nanopartícules
Emulsions (Farmàcia)
Skin
Nanoparticles
Emulsions (Pharmacy)
title_short Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
title_full Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
title_fullStr Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
title_full_unstemmed Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
title_sort Semi-solid functionalized nanostructured lipid carriers loading thymol for skin disorders
dc.creator.none.fl_str_mv Folle, Camila
Sánchez-López, E. (Elena)
Mallandrich Miret, Mireia
Díaz-Garrido, Natalia
Suñer Carbó, J. (Joaquim)
Halbaut, Lyda
Carvajal Vidal, Paulina Andrea
Marqués Villavecchia, Ana M.
Espina García, Marta
Badía Palacín, Josefa
Baldomà Llavinés, Laura
García López, María Luisa
Calpena Campmany, Ana Cristina
author Folle, Camila
author_facet Folle, Camila
Sánchez-López, E. (Elena)
Mallandrich Miret, Mireia
Díaz-Garrido, Natalia
Suñer Carbó, J. (Joaquim)
Halbaut, Lyda
Carvajal Vidal, Paulina Andrea
Marqués Villavecchia, Ana M.
Espina García, Marta
Badía Palacín, Josefa
Baldomà Llavinés, Laura
García López, María Luisa
Calpena Campmany, Ana Cristina
author_role author
author2 Sánchez-López, E. (Elena)
Mallandrich Miret, Mireia
Díaz-Garrido, Natalia
Suñer Carbó, J. (Joaquim)
Halbaut, Lyda
Carvajal Vidal, Paulina Andrea
Marqués Villavecchia, Ana M.
Espina García, Marta
Badía Palacín, Josefa
Baldomà Llavinés, Laura
García López, María Luisa
Calpena Campmany, Ana Cristina
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Pell
Nanopartícules
Emulsions (Farmàcia)
Skin
Nanoparticles
Emulsions (Pharmacy)
topic Pell
Nanopartícules
Emulsions (Farmàcia)
Skin
Nanoparticles
Emulsions (Pharmacy)
description Acne constitutes one of the most prevalent skin disorder affecting both skin and mental health of patients. However, no cure has been developed so far. In this area, Thymol constitutes a potential candidate since it is able to restore the healthy microbiota of the skin. However, its permeation properties cause its fast elimination and, to avoid this problem, thymol has been loaded into nanostructured lipid carriers (TH-NLCs). Moreover, to increase the suitability of these systems for skin applications, several surface functionalization strategies of TH-NLCs had been assessed. Among the different molecules, phosphatidylcholine-TH-NLCs demonstrated to be safe as well as to provide high antioxidant activity in cellular studies. Therefore, to administer these systems to the skin, functionalized TH-NLCs were dispersed into a carbomer gel developing semi-solid formulations. Rheological properties, porosity and extensibility of TH dispersed in carbomer as well as phosphatidylcholine-TH-NLCs were assessed demonstrating suitable properties for dermal applications. Moreover, both formulations were applied in healthy volunteers demonstrating that gel-phosphatidylcholine-TH-NLCs were able to increase in skin hydration, decrease water loss and reduce skin sebum. Therefore, gel-phosphatidylcholine-TH-NLCs proved to be a suitable system for skin pathologies linked with high sebum generation, loss of hydration and high oxidation, such as acne vulgaris. Keywords: Acne; Dermal; Lipid nanoparticles; Nanostructured lipid carriers; Thymol.
publishDate 2024
dc.date.none.fl_str_mv 2024
2025
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/219683
url https://hdl.handle.net/2445/219683
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1016/j.ijpharm.2023.123732
International Journal of Pharmaceutics, 2024, vol. 651
https://doi.org/10.1016/j.ijpharm.2023.123732
dc.rights.none.fl_str_mv cc-by-nc-nd (c) Camila Folle, et al., 2024
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by-nc-nd (c) Camila Folle, et al., 2024
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1 p.
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407191368204288
score 15,811543